Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 3Unresectable Non-small Cell Lung Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Nasopharyngeal Neoplasms 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 2Polymerase Chain Reaction 2Nicotine 2Immunohistochemistry 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Docetaxel 2Counseling 2Bupropion 2tocilizumab 1motexafin gadolinium 1fluoromisonidazole 1atezolizumab 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Taxes 1Rubidium-82 1Ritonavir 1Radiotherapy 1Psychiatric Rehabilitation 1Paclitaxel 1Nicotine Replacement Therapy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunoglobulin G 1FPP(RGD)2 1Endostatins 1Endoscopic Mucosal Resection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Endostatins × Thoracic × Clear all
NCT01347424 2013-12-09

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡